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Abstract: Efflux pumps represent an important and large group of transporter proteins found in
all organisms. The importance of efflux pumps resides in their ability to extrude a wide range of
antibiotics, resulting in the emergence of multidrug resistance in many bacteria. Besides antibiotics,
multidrug efflux pumps can also extrude a large variety of compounds: Bacterial metabolites,
plant-produced compounds, quorum-sensing molecules, and virulence factors. This versatility makes
efflux pumps relevant players in interactions not only with other bacteria, but also with plant or
animal cells. The multidrug efflux pumps belonging to the major facilitator superfamily (MFS) are
widely distributed in microbial genomes and exhibit a large spectrum of substrate specificities.
Multidrug MFS efflux pumps are present either as single-component transporters or as tripartite
complexes. In this review, we will summarize how the multidrug MFS efflux pumps contribute to the
interplay between bacteria and targeted host cells, with emphasis on their role in bacterial virulence,
in the colonization of plant and animal host cells and in biofilm formation. We will also address the
complexity of these interactions in the light of the underlying regulatory networks required for the
effective activation of efflux pump genes.
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1. Introduction
Efflux pumps (EPs) are found in all living organisms [1–3]. In many bacteria EPs extrude a wide
range of antibiotics, strongly contributing to the emergence of multidrug resistance (MDR) [4–7]. As this
poses an enormous threat to public health, MDR EPs have been mainly studied in clinically relevant
bacteria. Several investigations suggest that the genes encoding MDR EPs cannot be simply considered
as the result of recent evolution facilitated by intense antimicrobial therapy, but rather appear to
be ancient genes encoding cellular transmembrane devices deeply involved in the physiology and
ecology of all organisms [3,8–13]. This view is consistent with the fact that MDR EPs can extrude a large
variety of compounds besides antibiotics, e.g., bacterial metabolites, heavy metals, plant signaling
compounds, organic pollutants, quorum-sensing molecules, and virulence factors. This high versatility
makes EPs relevant players in the maintenance of cellular homeostasis, in bacterial interactions
with plant and animal hosts, in biofilm formation, and in the adaptation of bacteria to an assorted
range of habitat [7,10–12,14,15]. Interestingly, the number of MDR EPs is proportional to genome
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size [9,16], which in turn is known to be dependent on the ecological behavior of bacteria. Free-living
organisms generally have large genomes, carrying all genes required for the colonization of different
environments [17]. They host a much higher number of MDR systems as compared to endosymbionts
or to some pathogens, which have smaller genomes as a consequence of reductive evolution [18,19].
In general, bacterial species from the same genus share most EP genes, although some variability exists
due to EP determinants carried by mobile genetic elements.
Based on several criteria, such as sequence similarity, energy source, transport function and
substrate specificity, EPs have been traditionally grouped into five large families: The ATP-binding
cassette (ABC), the major facilitator (MFS), the resistance-nodulation-cell division (RND),
the multidrug/oligosaccharidyl-lipid/polysaccharide (MOP) flippase, and the drug/metabolite
transporter (DMT) families [2,4,7]. Two new transporter families, the proteobacterial antimicrobial
compound efflux (PACE) family [20] and the p-aminobenzoyl-glutamate transporter (AbgT) family [21],
were recently identified. Proteins belonging to the PACE family transport biocides, e.g., acriflavine,
while those of the AbgT family are involved in the transport of sulphonamides. ABC transporters
directly couple the efflux function to ATP hydrolysis, whereas members of the other EP families are
powered by electrochemical gradients across the inner membrane.
The structure of MDR EPs of the MFS family and their specific role in antibiotic resistance has
been widely covered by several recent reviews [6,7,13,22–28]. In this review we focus on other roles of
these EPs when bacteria interact with plant, animal and microbial cells. In particular, we address their
involvement in bacterial virulence, in the colonization of host cells and in biofilm formation. We also
describe the main strategies adopted by bacteria to allow efficient and coordinate expression of MFS
EPs in response to environmental stimuli.
2. Organization and Evolution of the MFS EPs
In both Gram-negative and Gram-positive bacteria EPs are commonly present as single-component
efflux transporters in the inner membrane. In Gram-negative bacteria, they can also form tripartite
complexes spanning across both membranes [2,28,29]. Multicomponent EPs have been found among
the transporters of the ABC, MFS, and RND families and consist of an inner membrane transporter,
a periplasmic adaptor (PA, also known as a membrane fusion protein, MFP), and an outer membrane
protein, all of them essential for pump functionality [24,25,28,29].
The MFS EP family constitutes the largest group of secondary membrane transporters and is
present in all phyla, from bacteria to plants and mammals [27,30–32]. MFS transporters function
mostly in the uptake of sugars, but several MFS proteins are also involved in drug efflux systems,
thus contributing to antibiotic resistance both in Gram-negative and Gram-positive bacteria. The MDR
MFS transporters are widespread among microbial genomes and generally act as single-component
pumps able to transport small solutes across the inner membrane (Figure 1). In Gram-negative bacteria,
several MDR MFS pumps are constituted by a tripartite complex [28,29,32] encoded by genes organized
in a single operon. In particular, the gene coding for the outer membrane protein is followed by the
genes encoding the periplasmic adaptor and the inner membrane transporter. Most often a regulatory
gene, either activator or repressor, lies beside and is transcribed independently from the EP encoding
genes (Figure 2). The organization of MFS tripartite EPs encoding genes is reversed as compared to
RND EPs, where the gene encoding the transporter is always located in a promoter-proximal position
followed by the gene coding for the periplasmic protein and then, when present, by the gene encoding
an outer membrane component [11].
Bioinformatic analyses based on the alignment of conserved motifs suggest that the MFS
transporters can be divided into two groups, containing 12 or 14 transmembrane helices or segments
(TMS) [27,32]. Despite this variation, the current hypothesis is that both groups have evolved from
a simple prototype carrying a hairpin structure with two TMS [32]. This protein may have triplicated
into a larger molecule containing six TMS, which in turn may have formed a 12-TMS structure by
a successive duplication event. MFS transporters with 14 TMS have two extra, centrally positioned,
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TMS that are believed to result from intragenic duplication. These transporters can give rise to tripartite
pumps which directly transport substrate from the cytoplasm to the outer environment [24,28,29].
The crystal structure of EmrD, a MDR MFS protein, reveals the general architecture of the 12-TMS
drug transporters [33]. While eight TMS form an internal cavity, the remaining ones face towards the
outside. Most residues in the cavity are hydrophobic, in line with the role in transporting lipophilic
molecules, and are conserved in other transporters of the MFS family. According to the classical view,
once the drug has entered the cavity, it is transported through a rocker-switch model [33,34]. Recent
structural evidence has led to an update, the so-called clamp-and-switch model: A two-step mechanism
which better accounts for the structural changes occurring in individual transmembrane helices [27].
In particular, bending of the helices lining the internal pore is assumed to give rise to an occluded state
(clamping step). Then the domains would alternatingly rotate, exposing the binding domain to one or
the other side of the inner membrane (switching step).
Figure 1. Schematic overview of the architecture of the efflux pumps of the major facilitator superfamily
(MFS). Multidrug MFS efflux pumps are typically found as single-component efflux transporters in the
inner membrane (IM). In Gram-negative bacteria, MFS transporters can also form tripartite complexes
that directly transport substrates from the cytoplasm to the exterior. The inner membrane component
does not extend into the periplasm (P) but is thought to interact with a periplasmic adaptor protein
within the inner membrane. The adaptor protein forms a sealed channel between the inner and outer
membrane (OM) components. The outer membrane channel is constituted usually by the TolC protein.
In some cases a TolC-like protein, encoded by the same operon as the inner membrane and periplasmic
components, acts as an outer membrane channel.
Exit of substrates through the outer membrane occurs, in most cases, via the TolC protein. TolC is
a trimeric outer membrane protein characterized by the presence of an α-barrel projecting across the
periplasm and linked to a β-barrel domain embedded in the outer membrane [35]. TolC serves as
an external channel not only for the EPs of the MFS family, but also for EPs of the RND and ABC
families, thus showing a remarkable substrate versatility. TolC-like proteins are often encoded by the
MFS operon [24,36,37] (Figure 2) indicating that in a wide range of bacteria, TolC-type features are
a structural requirement for the assembly of a tripartite MFS EP [29,35]. The architecture of tripartite
efflux pumps provides a continuous seal so that exported compounds can bypass the periplasm
(Figure 1). In the case of RND tripartite EPs, the seal is ensured by a close fit between the periplasmic
domains of TolC and of the inner membrane component, which is further stabilized by the adaptor
component of the pump [11,25,29]. Structural studies of the MFS EmrAB-TolC EP of Aquifex aeolicus
suggest that the inner membrane transporter does not contain significant periplasmatic domains and
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the seal is likely the result of the interaction between the adaptor protein and the periplasmatic domain
of TolC [23].
Figure 2. Genetic organization of representative MFS efflux pumps (EP) encoding genes and their local
regulators. MFS transporters are encoded by chromosomal or plasmid genes. The genes encoding
the inner membrane transporter (yellow) and the periplasmic adaptor protein (brown) are part of
a single operon. The outer membrane channel protein (blue) may be encoded by the same operon
or by another genetic locus, as in the case of the tolC gene. The transcriptional regulation of MFS EP
genes is controlled mainly by local regulatory genes encoding repressors (red) or activators (green).
In general, local regulators allow the expression of MFS EP operons in response to the substrates
they export. Repressors belong to the TetR-, MerR- or MarR- families while activators belong to
LysR- or MerT-families. The evgA gene (light green) encodes the regulator of a two-component system
(EvgA/EvgS) which activates the emrKY operon in response to high concentrations of alkaline metals
under mild acidic concentrations, as found inside macrophages. Global regulators are not shown in
the figure.
3. Transcriptional Strategies for the Regulation of MFS EPs
The dynamic adaptation of bacteria to the highly diverse habitats relies on their capability to
quickly sense environmental variations and respond in a way which frequently implies severe changes
in the transcriptional profile of the cell. As EPs are able to extrude a wide range of structurally unrelated
chemicals, it is reasonable to assume that their altered expression may lead to an unbalanced efflux
of metabolites or other signaling molecules and adversely affect cell physiology. Not surprisingly,
the expression of EPs is usually well-tuned and, under physiological conditions, occurs only at a low
level [13,38]. Remarkably, different bacterial species share common EP regulatory circuits: Expression
patterns found in aerobic bacteria are also present in microaerobic and anaerobic species [38,39].
The regulation of MFS EP synthesis most often relies on a transcriptional repressor belonging to
the TetR-, MarR- or MerR-type [38]. Activation occurs after an effector binds to the repressor protein,
making it unable to exert its function. A well-known example of this regulation is the induction of E. coli
emrAB by inactivation of the EmrR repressor [40]. The emrAB operon encodes the EmrB transporter and
Microorganisms 2019, 7, 285 5 of 21
the EmrA periplasmic adaptor of a MDR tripartite EP (Figure 2). As an outer membrane component,
the EmrAB EP uses the TolC protein. The emrR gene is located immediately upstream the emrAB
genes and is independently transcribed. EmrR binds directly to the promoter region of emrAB and
inhibits its transcription under non-inducing conditions [41]. Toxic chemicals, which act as EmrAB
substrates (e.g., carbonylcyanide-3-Chlorophenylhydrazone, 2,4–dinitrophenol (CCCP) or ethidium
bromide), bind to EmrR inducing conformational changes that weaken its interaction with the promoter,
thus relieving emrAB repression. Additionally, in the human pathogen Vibrio cholerae VceCAB, an MDR
EP sharing homology with EmrAB, is negatively regulated by a TetR-like repressor VceR. VceCAB
confers resistance to several antibiotics, CCCP and deoxycholate and is encoded by a large operon also
including the outer membrane component VceC [42]. VceC has a high degree of structural similarity
with TolC although a wide divergence exists at the primary sequence level [43]. The mechanism
leading to the derepression of the vceCAB operon has been studied in detail using CCCP as pump
substrate. In particular, it has been shown that VceR is able to bind CCCP but that its affinity for this
substrate decreases in the presence of DNA, suggesting that the equilibrium between free VceR and
CCCP-bound VceR is critical for the synthesis of the pump [44].
A further example of negative control of MFS EP genes is represented by the farAB operon,
which encodes an EP system that mediates resistance of Neisseria gonorrhoeae to antimicrobial long-chain
fatty acids [45]. The expression of farAB operon is negatively controlled by the FarR repressor,
belonging to the MarR family, which binds to three sites within the promoter region [46]. Repression
by FarR is enhanced by binding of the nucleoid protein IHF to the farAB promoter, inducing DNA
curvature. This conformational change stabilizes the FarR-DNA complex and results in strong
repression of farAB [47], stressing the relevance of DNA bending in the regulation of gene expression
in bacteria [48,49]. Expression of farAB is also controlled by MtrR, a regulator that normally represses
mtrCDE, which encodes another EP involved in resistance to long-chain fatty acids. MtrR plays an
indirect role as it does not bind directly to the farAB promoter, but rather represses the transcription of
farR and thus alleviates the FarR-mediated repression of farAB [46]. Other EPs sharing homologies with
E. coli EmrAB exist in several bacteria interacting with plant and animal cells as will be discussed in
detail in the following sections. Here, we just stress that also in these cases, repression by an EmrR-like
protein is relieved in response to stimuli from the host.
In addition to EmrAB-like pumps, other examples of MFS EP genes submitted to negative control
are worth mentioning. In Listeria monocytogenes, the expression of the MdrT pump is under the negative
control of the TetR-like repressor BtrA [50]. BtrA loses the ability to bind to and repress the mdrT
promoter in the presence of cholic acid, thus facilitating bacterial survival in host bile-rich environments.
BtrA is also responsible for the cholic acid-dependent induction of another MFS efflux pump, MdrM,
which is negatively controlled by the local repressor MarR [50,51]. Another case of repressor released
from the promoter following binding of specific ligands is QacR, the regulator of the multidrug
transporter QacA. QacA has been among the first bacterial MDR transporters identified [52] (Figure 2).
It is encoded by plasmids as pSK1, frequently associated with Staphylococcus aureus and other relevant
human pathogens [38]. The cognate encoding regulator gene qacR is divergently transcribed from
qacA and binds to the regulatory region upstream qacA, thus inhibiting its transcription [38]. Cationic
lipophilic compounds, as well as several synthetic antimicrobial substances, bind to QacR resulting in
its dissociation from the promoter, which in turn enables expression of qacA. Interestingly, QacA is also
activated by the plant alkaloid berberine. These observations suggest that berberine may be a natural
substrate of QacA and that the QacA-QacR system, originally providing resistance to plant and other
naturally derived antimicrobial compounds, has been successively recruited by bacterial pathogens to
survive in the presence of antimicrobial agents used in clinical therapies [38]. An interesting regulatory
pathway is represented by Tet38, another MDR EP of S. aureus [53,54]. Transcription of tet38 is repressed
by a TetR-like regulator, TetR21. Tet38 substrates, such as tetracycline or palmitoleic acid, disrupt the
TetR21-tet38 promoter complex, allowing expression of the tet38 containing operon [54]. The tet38
gene is also under the negative control of the global regulator MgrA [55]. MgrA is able to bind to
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the tetR21 promoter but not to the tet38 promoter, suggesting that it indirectly contributes to the
repression of tet38 by increasing the transcription of tetR21. Another S. aureus MDR EP, NorB, is under
the direct control of MgrA [55]. In its phosphorylated form MgrA binds as a dimer to the norB
promoter, repressing its transcription. The norB gene is highly expressed in the host environment,
especially in abscesses and is important for survival in such locations [56]. The relative expression level
of norB is also found up-regulated during S. aureus biofilm growth [57]. Under the mildly acidic and
low-oxygen environment found in abscesses and possibly within the core of biofilms, MgrA undergoes
post-transcriptional modifications, which result in alleviation of its repressive activity on norB [55].
In contrast to NorB and Tet38, NorD, a further MDR MFS EP of S. aureus, is not submitted to the control
of MgrA. The norD gene is repressed by Fur and is induced in iron-restricted environments, a condition
which bacteria frequently encounter within mammalian hosts [58].
The expression of MFS pumps can also be activated by transcriptional regulators which, in response
to specific inducers, facilitate the binding of RNA polymerase to the corresponding promoters. This is
exemplified by Bmr, an MFS multidrug transporter of Bacillus subtilis. It is positively regulated by BmrR,
a MerR-like regulator encoded in the same locus [59]. BmrR is activated by a large range of structurally
diverse hydrophobic molecules, including toxic compounds transported by Bmr [38]. Binding of
BmrR to the bmr promoter induces a conformation compatible with intense transcription. A complex
mechanism based on localized base-pair breaking, base sliding and realignment allows BmrR to
upregulate transcription by reconfiguring the 19-base-pair spacer between the -35 and -10 promoter
elements for highly productive interaction with RNA polymerase. Besides BmrR, also another MerR-like
regulator, the global regulator Mta, activates the bmr gene by binding the same promoter site as BmrR.
A similar circuit, requiring both local and global positive regulators, activates Blt, an MDR EP sharing
50% aminoacid identity with Bmr [59]. In contrast to bmrR the gene encoding the local regulator bltR
is divergently transcribed from the blt gene and is not activated by Blt substrates (Figure 2). Blt has
been shown to be involved in the efflux of polyamines [60], small molecules emerging as relevant
players in bacteria-host interactions [61,62]. In this case, the Mta global regulator is also required for
the full expression of blt gene [38]. Another operon submitted to positive control is salAB in Rhizobium
leguminosarum [63]. It is activated by SalR, a LysR-like regulator, in response to phenolic compounds
released by the plant (Figure 2).
EPs can also be controlled by two-component signal transduction systems (TCS). These systems
typically respond to environmental conditions by means of an inner membrane histidine kinase that
senses and transduces different signals phosphorylating a response regulator. A global analysis of the
role of TCS in the regulation of E. coli EPs [64] has evidenced that TCS systems like BaeSR, CpxAR,
and EvgAS control several pumps in response to different stimuli. Among MFS efflux pumps, EmrKY is
regulated by EvgAS in mildly acidic media and under high concentrations of alkaline metals [65,66].
The EvgAS system is encoded by an operon divergently transcribed from the emrKY genes (Figure 2).
Recently, it has been observed [66] that the same stimuli (K+ and acidic pH) acting on the EvgAS
system also control ermKY expression in Shigella flexneri, a human life-threating pathogen [67,68].
In particular, the analysis of emrKY expression during the intracellular life of Shigella has shown that the
same regulation also occurs inside macrophages, where, following Shigella infection, the pH decreases
favoring the activation of emrKY transcription by the EvgAS system [66].
4. Role of MFS EPs in Interactions Between Bacteria and Plant Cells
Plants produce a large array of secondary metabolites, such as phytoalexins and alkaloids,
which protect them from pathogens [69]. On the other hand, bacterial plant pathogens have evolved
systems to counteract this chemical barrier. Several studies have shown that, among these systems,
MDR tripartite EPs are key elements in conferring resistance to plant toxic compounds, thus facilitating
the colonization of the host by bacteria [3,7,15]. In addition, EPs are also involved in interactions
between plants and symbiotic bacteria such as rhizobia, well known for their capacity to form
nitrogen-fixing nodules on the roots of legumes. Within the RND EP family several cases have been
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described illustrating the involvement of these pumps in resistance to toxic compounds, nodulation
and interspecies signal trafficking [11,12]. Some MFS EPs are relevant to plant-cell interactions in
both pathogenic and symbiotic bacteria (Table 1). Two MFS EPs, Emr1AB and Emr2AB, analogous
to the E. coli EmrAB EP, have been shown to be involved in the virulence of Erwinia chrysanthemi,
the causative agents of soft root disease [70]. Virulence of E. chrysanthemi is a complex process that
depends on several factors, including plant cell wall degrading enzymes causing maceration and
necrosis of plant tissues [71]. Some interesting differences have been outlined comparing the virulence
of emr1AB or erm2AB mutants in infection assays with different host plants. Indeed, while infection
with E. chrysanthemi emr2AB mutants gives rise to a reduced necrotic area in African violet and in
chicory leaves, emr1AB mutants exhibit reduced virulence only in the African violet host. The fact that
emr2AB mutants do not grow in chicory leaves suggests that the lack of Emr2AB drastically affects
the ability of E. chrysanthemi to initiate plant colonization. On the other hand, mutants defective in
emr1AB are extremely sensitive to potato extracts and their ability to infect potato tubers is severely
reduced [70]. The toxic compound present in chicory and in potato tuber extracts has not been identified.
Besides sharing the ability to confer resistance to a large panel of antibiotics, Emr1AB and Emr2AB also
provide resistance to oleic acid and, respectively, to all phytoalexins. Taken together, these data suggest
that the function of these EPs may be related to the transport of specific toxic compounds found only
in a given plant host. Moreover, Ravirala et al. [72] have demonstrated that the expression of emrA
in E. chrysantemi 3937 is increased three-fold in the presence of salicylic acid and up to five-fold in
response to a combination of phenolic acids (including salicylic acid, benzoic acid and trans-cinnamic
acid), thus confirming that the exploitation of plant defence signaling by bacteria to activate EPs may
have evolved to increase resistance to toxic molecules and thus ease survival in a hostile environment.
As for the involvement of the MFS EPs in symbiotic interactions between bacteria
and plants, specific systems have been characterized in Rhizobium etli, Sinorhizobium melitoti,
and R. leguminosarum [63,73–76]. A flavonoid inducible MFS efflux pump, RmrAB, has been described
in R. etli, a mutualistic symbiont of Phaseolus vulgaris. The rmrA and rmrB genes are divergently
transcribed from a gene encoding a regulator of the TetR family [74] (Figure 2). Mutants defective in
rmrA or rmrB form fewer nodules on bean roots and have an increased sensitivity to toxic compounds
as naringenin, phytoalexins and salicylic acid. Interestingly, the ability to grow in the presence of a
high concentration of naringenin is restored in the presence of a plasmid encoding the E. coli EmrAB
pump [74]. Besides underlining the functional similarity between the E. coli emrAB genes and the rmrAB
genes of R. elti, this study reveals how MFS EPs are involved in nodule formation and in resistance to
plant flavonoids. A systematic study of efflux systems in rhizobia has been carried out in S. melitoti,
a symbiont of alfalfa, to better understand the effect of the loss of MDR EP genes on the resistance to
antimicrobials and on symbiosis [76]. S. melitoti interacts with legume roots inducing the formation of
nodules within which the bacterium fixes nitrogen to ammonia that becomes available to the plant.
By bioinformatic analysis several MDR tripartite EP systems have been identified [76], including three
belonging to the MFS family. Among them there is an EmrAB system which shares homologies with
the E. coli EmrAB EP. The expression of the emrAB gene of S. melitoti is under the control of a TetR-like
EmrR repressor [73,77] and occurs in response to stimuli from the plant. Using an emrA::gusA fusion it
has been shown that emrAB genes are induced by several flavonoid compounds as luteolin, quercetin,
galangin, naringenin and apigenin produced by the plant in response to bacterial colonization [77].
In particular, it has been shown that in vitro luteolin interferes with the binding of the EmrR repressor
to the emrAB regulatory region, accounting for the higher expression of the emrAB operon in response
to flavonoids. Deletion of the emrAB operon does not affect neither the S. melitoti sensitivity to several
toxic compounds nor the symbiotic properties. While these data seem to rule out an involvement of
this EP in the symbiotic process, expression profiling analysis shows that the emrAB operon and the
ermR regulatory gene are also inducible by heat shock and low pH, indicating a possible role for this
EP in the response to stress [75]. Moreover, the loss of EmrR strongly decreases the ability to form
nodules and the competitiveness against the wild-type in co-inoculation experiments with Medicago
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sativa as host [73]. This suggests that EmrR also regulates other genes of S. melitoti and that it is an
important player for the successful interaction of the bacterium with the plant.
A key molecule in the response of plants to microbial colonization is salicylic acid, a phenolic
hormone with multiple roles in plant metabolism and physiology [78]. Amongst R. leguminosarum bv
viciae 3841 genes upregulated in response to salicylic acid, two operons, salAB and rmrAB, encode MFS
EPs [63]. The rmrAB genes are located on a plasmid and share high homology with the corresponding
system of R. etli CFN42 [74]. The salAB genes represent a novel system, which is organized in an operon
divergently transcribed from the salR regulatory gene (Figure 2). SalR is specifically activated by
salicylic acid and to a lesser extent by acetylsalicylic acid [63]. Mutagenesis analyses reveal that deletion
of salA, but not of rmrA, significantly increases the sensitivity to salicylic acid [63]. This is in contrast
with the observed capacity [74] of the RmrAB pump to confer resistance to salicylic acid in R. etli.
Another relevant difference, as compared to R. etli is found at the functional level: in pea plants,
it has been observed that mutants lacking salA or rmrA do not exhibit alterations in the nodulation
capacity or in the rate of nitrogen fixation [63]. While this is expected for salA, as it is expressed at low
levels in nodule bacteria, it is particularly surprising for RmrAB since its genes are highly upregulated
(more than 20-fold) during bacteroid development. This opens the possibility of a novel, yet undefined
role of the RmrAB pump in plant-bacterium interactions.
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Table 1. Efflux pumps of the MFS family involved in interactions with plant, animal, and bacterial cells.
Effux Pump * Microorganism Main Functions ** Reference
Interaction with plants
EmrAB Erwinia chrysanthemi Virulence in potato, resistance to phenolic acids [70,72]
EmrAB Sinorhizobium melitoti Response to plant induced luteolin [73,77]
RmrAB Rhizobium etli nodule formation, resistance to plant flavonoid [74]
SalRAB Rhizobium leguminosarum Resistance to salicylic acid [63]
Interaction with animal cells
EmrKY Shigella flexneri Survival in macrophages [66]
EmrAB Escherichia coli Resistance to bile salts [40]
FarAB Neisseria gonorrhoeae Resistance to long-chained fatty acid [45]
MdrT Listeria monocytogenes Export of cholic acid and c-di-AMP [51,79]
MdrM L. monocytogenes Export of c-di-AMP [79]
Tet38 Staphylococcus aureus Internalization and survival in epithelial cells [53,54,80]
NorB S. aureus Survival in abscesses and in biofilms [56,57]
NorD S. aureus Survival in abscesses [58]
P55 Mycobacterium tuberculosiMycobacterium bovis Survival in macrophages and in mouse model [81,82]
Tap M. tuberculosis Survival in macrophages [83–85]
VceCAB Vibrio cholerae Resistance to bile salts [42]
Bacterial communication and
Biofilm formation
EmrCAB Chromobacterium violaceum Quorum-sensing signaling [37]
AbaF Acinetobacter baumannii Biofilm formation, virulence [86]
AbaQ A. baumannii Surface—associated motility, virulence [87]
Pmt A. baumannii Nucleic acid transporter—biofilm formation [88]
SetB E. coli Biofilm formation [89]
TetAC E. coli Biofilm maturation [90]
EmrD E. coli Biofilm formation [91]
GluP Helicobacter pylori Biofilm formation [92]
ProP S. aureus Protection from osmotic stress [93]
EmrCABsm Stenotrophomonas maltophilia Extrusion of environmental molecules [36]
* In the case of tripartite EPs, the outer membrane component is indicated only when co-transcribed in the same operon. ** With the exception of FarAB, Pmt, SetB, and ProP all EPs confer
resistance to one or more antibiotics.
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5. Role of the MFS EPs in the Virulence of Bacterial Pathogens in Animal Hosts
Several studies indicate that MDR MFS EPs actively contribute to the virulence of bacterial
pathogens. These EPs can be required for colonization and dissemination during host infection,
being involved in the resistance to defence compounds produced by the host (Table 1). In some cases
they can be directly implicated in the invasion process. Examples of MFS EPs that mediate resistance to
host-derived antimicrobials, favoring pathogen dissemination in the host, are found in N. gonorrhoeae
and L. monocytogenes.
It has been demonstrated that the FarAB EP mediates resistance of N. gonorrhoeae to long-chained
fatty acids (FA) such as oleic, linoleic and palmitic acids [45]. N. gonorrhoeae is a strict human pathogen
causing gonorrhea, a sexually transmitted disease. Although the gonococcus is most often responsible
for urogenital infections it can infect other mucosal surfaces, such as the rectum or the oropharynx
mucosae. Several host antibacterial mechanisms operate at different infection sites. The major actor
conferring resistance to antimicrobial compounds present on mucosal sites is the RND pump MtrCDE,
which is involved in the export of several host-derived hydrophobic agents [94]. A study by Lee
and Shafer [45] identified FarAB as a second efflux system involved in gonococcal resistance to
a specific subset of long-chained FAs. Indeed, the authors were able to demonstrate that farB insertional
mutants of clinical isolates have acquired high susceptibility to those FAs. The far (for “FA resistance”)
system is composed of the FarA adaptor protein and of the FarB cytoplasmic membrane transporter.
Both display sequence similarity with the E. coli EmrAB. This EP requires the MtrE protein as outer
membrane channel to export antibacterial FAs from inside the cell. As discussed, the expression
of farAB is negatively regulated by FarR, which, in turn, is repressed by MtrR, the repressor of the
mtrCDE EP [46,95]. The opposite activity of MtrR on the mtr and far operons likely prevents abnormal
expression of EPs, which has been demonstrated to be harmful to gonococci [96]. At the same time it
provides gonococci with an alternative way to counter host-innate defences, as in the case of resistance
to the antibacterial effects of FAs present in faecal lipids observed in a subset of rectal isolates [97].
A study assessing the transcriptional response of L. monocytogenes to mammalian bile has identified
that two MDR MFS EPs, MdrM and MdrT, are strongly induced by the bile component cholic acid [50].
Mammalian bile displays a potent anti-microbial activity. Bacterial pathogens of the gastrointestinal
tract and the hepatobiliary system must be able to survive in these bile-rich environments in order to
colonize host cells and disseminate during infection [98]. L. monocytogenes is a foodborne pathogen,
which, initially resides within the intestine and then crosses the intestinal barrier, rapidly disseminating
to liver and spleen, the primary target organs. The bacterium can also persist extracellularly within
the gallbladder lumen, where bile is highly concentrated. Several genes contribute to the survival of
L. monocytogenes in bile-rich environments [99]. The mdrM and mdrT efflux pump encoding genes are
among them and are strongly induced by cholic acid. However, only one of the two pumps, MdrT,
is able to extrude this compound and this results in the capacity of L. monocytogenes to survive in
a bile-rich environment. The deletion of mdrT attenuates growth in the presence of cholic acid in vitro
and causes a 100-fold reduction of mouse gallbladder colonization in vivo. The MdrT EP is thus
regarded as an important virulence factor of L. monocytogenes [50]. As far as MdrM is concerned, it has
been suggested that it can synergize with MdrT in L. monocytogenes mouse liver colonization although
the exogenous substrates of this EP have not yet been identified [50].
The role of the MFS MdrM and MdrT EPs is not limited to bile resistance. Indeed, they are known
for their involvement in the pathogenesis of L. monocytogenes and for their ability to modulate the
cytosolic surveillance pathway of innate immunity, favoring bacterial intercellular spread and tissue
invasion. In particular, ectopic expression of both MdrM and MdrT leads to the massive activation of
IFN-β in infected mouse macrophages, while deletion of the mdrM gene reduces the secretion of IFN-β,
suggesting that MdrM actively controls the capacity of cytosolic bacteria to induce IFN-β expression [51].
Taking advantage of a L. monocytogenes strain overexpressing mdrT it was possible to identify the
molecule secreted by MdrT as cyclic-di-AMP. It has been suggested that under physiological conditions
MdrM stimulates IFN-β production by transporting this natural, non-toxic substrate [79]. Subsequently,
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other MdrM-homologs were identified. Together with MdrM they are responsible for most of the
IFN-β induction during L. monocytogenes infection of mouse macrophages [100]. These molecules,
collectively referred to as MTAC transporters (for MdrM, MdrT, MdrA, and MdrC), are highly induced
during bacterial infection. Although they are not necessary for bacterial growth in macrophage cells
their lack impairs L. monocytogenes virulence in mice [100]. In these studies c-di-AMP released by
MTAC transporters has clearly shown its capacity to induce a controlled activation of cytosol sensing
pathways, which appears to be beneficial to the L. monocytogenes infectious process in vivo. More recent
findings have shed light on how secreted cyclic-di-AMP is pivotal for L. monocytogenes virulence.
It has been demonstrated that the primary sensor for this cyclic dinucleotide is the oxidoreductase
RECON (a reductase controlling NF-κB) [101] which upon binding of c-di-AMP, releases the negative
control on NF-κB activation downstream TLR (Toll-like receptor) engagement, eventually leading to
nitric oxide production. High nitric oxide improves L. monocytogenes intercellular spread, the most
consistent virulence feature of epidemic strains [102]. MTAC transporters also play a role in the stress
response of the L. monocytogenes cell wall. It has been suggested that MTAC transporters are involved
in enhancing peptidoglycan synthesis under stimuli that produce cell wall stress, such as vancomycin,
and that a link between this function and c-di-AMP secretion may exist [100]. Moreover, induction
of MTAC-dependent IFN-β in infected macrophages was found to be triggered by L. monocytogenes
mutants defective in lipoteichoic acid (LTA) synthesis. Under normal growth conditions LTA synthesis
itself has been demonstrated to require MDR transporters, possibly via c-di-AMP efflux [103].
Another example of an efflux system involved in physiological functions, such as lipid metabolism,
and, at the same time crucial for the virulence phenotype, has been described in mycobacteria.
It consists of the lipoprotein LprG and the MDR MFS efflux pump P55. LprG and P55 are encoded
by the rv1411c-rv1410c operon, which is conserved across several non-pathogenic and pathogenic
species of mycobacteria, including Mycobacterium bovis and Mycobacterium tuberculosis [104]. Several
studies have demonstrated that this operon is essential for the virulence of various mycobacterium
species in mice, as deletion of rv1411c-rv1410c reduces bacterial replication in macrophages and
survival in mouse models [81,82,105]. In M. tuberculosis the LprG-P55 system was found to translocate
triacylglycerides (TAG) from the cytoplasm to the outer membrane through a mechanism where P55
transports TAG across the inner membrane and passes it to LprG, which then transfers it to the outer
membrane [106]. In the host lipids represent the major source of carbon for M. tuberculosis and these
conditions favor the production of TAG, which serves as a reliable long-term energy source. It has been
proposed that the LprG-P55 transport system critically contributes to preventing abnormal intracellular
TAG accumulation during certain growth conditions within the host, protecting the bacteria from
toxic byproducts of cholesterol by discarding them via TAG from the cytoplasm [106]. The role of
the P55 EP in the pathogenesis of Mycobacterium is further stressed by high throughput screening
studies indicating that transposon mutants of the rv1410c gene are significantly attenuated in mouse
models [107] and in macrophages [108]. Accordingly, in M. bovis P55 has been found to be involved
in cholesterol uptake and required for optimal growth on cholesterol, one of the major sources of
carbon in vivo [109]. In mycobacteria the functions of MFS transporters are mostly linked to intrinsic
and acquired drug resistance which is responsible for the treatment failures of tuberculosis [110].
However, upregulation of MFS transporters may not necessarily depend on drug stress, and drug
tolerance may be a side effect of their physiological role, including virulence. Using a model consisting
of Zebrafish larvae infected with Mycobacterium marinum, it has been demonstrated that growing
mycobacteria develop multidrug tolerance soon after they infect macrophages, independently from
drug exposure. Drug tolerance is maintained for hours after macrophage killing and depends on the
activity of EPs [83]. In M. tuberculosis the Tap efflux pump is encoded by rv1258c, one of the genes
transcriptionally induced upon macrophage infection [84,85]. Deletion of rv1258c results in reduced
intracellular growth and hypersusceptibility to rifampicin, indicating the specificity of the Tap EP in
mediating macrophage-induced tolerance [83]. Subsequently, in M. tuberculosis it has been reported that
rv1258c is among the genes whose expression is induced in response to the lysosomal soluble fraction
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(SF) prepared from activated macrophages and that its deletion determines higher susceptibility to
killing by lysosomal SF, as well as attenuated survival in macrophages [111]. Tap represents an example
of EP induced upon host infection to counteract a hostile cell environment and promote bacterial
growth, which is implicated in mediating drug tolerance.
The involvement of the MDR MFS EPs during infections by bacterial pathogens is further
highlighted by Tet38, a Staphylococcus aureus EP which contributes to the bacterial internalization
and survival within host cells [53,54,80]. Tet38 is a chromosomally encoded EP that is responsible
for the extrusion of several substrates, including tetracycline, fosfomycin, and unsaturated fatty
acids. S. aureus is a versatile bacterium able to cause acute and chronic infections in humans and
animals due to its large arsenal of virulence factors and its ability to acquire multiple drug resistance.
The persistence of S. aureus may be due in part to its capability to survive in and adapt to the host
intracellular environment, enabling escape from the effects of antibiotics and of the host immune
response. Although S. aureus is usually not an intracellular pathogen it can invade epithelial and
endothelial cells and survive within them. The involvement of Tet38 in the uptake of S. aureus by host
cells has been clearly demonstrated by observing the severe reduction in the recovery of S. aureus tet38
mutants after invasion of human epithelial cells [54]. Tet38 interacts with the membrane-associated
host cell receptor CD36. Once inside the host cell Tet38 contributes to the escape of internalized
S. aureus cells from phagolysosomes [80]. Indeed, Truong et al. [80] have shown that while intracellular
tet38 S. aureus mutants remain mainly associated with the phagolysosome with a progressive decrease
in their number due to their failure to replicate, the wild-type strains are present in a greater number
of cells not associated with the phagolysosome. In addition to the tet38 gene, also the norB and norD
genes, encoding two MFS MDR transporters, are strongly upregulated during S. aureus infections
in a mouse subcutaneous abscess model [53]. Although their specific role and the potential natural
substrates within abscesses have not yet been identified, norB or norD mutants display significant
fitness defects in competition assays as compared to the wild-type [56,58]. In particular, in S. aureus
norD mutants the selective fitness impairment is greater than in norB mutants. These data indicate
that NorB and NorD EPs not only contribute to increasing the antibiotic resistance, but also facilitate
bacterial survival within staphylococcal induced abscesses.
Very recently the MFS EmrKY EP has been demonstrated to facilitate survival of Shigella within
a macrophage environment [66]. The infectious process of Shigella, a human intracellular pathogen,
is characterized by the ability to invade macrophages, where it multiplies and induces cell death,
before being released and then internalized by the epithelial cells of the colonic mucosa [67,68].
Despite a high genome homology with the commensal E. coli, Shigella has undergone extensive gene
decay [19,112], resulting in the lack of 6 out of 20 MDR EP systems described in E. coli [66]. Analyses of
the transcription of EP genes in response to the intracellular environment Shigella encounters during
the infectious process have shown that the EmrKY EP is selectively induced in macrophages but not in
epithelial cells [66]. It has been proposed that this may depend on the different cytosolic pH conditions
occurring in the two cell types. In particular, the acidic conditions met in macrophages induce emrKY
via the EvgA/EvgS two-component system. Competition experiments with Shigella strains containing
or lacking the emrKY operon reveal that EmrKY helps Shigella to better survive inside macrophages [66].
It has been reported that E. coli emrKY mutants, besides having a reduced ability to form biofilms,
exhibit hypersensitivity to several drugs, such as mitomycin C, a DNA alkylating agent [113]. On this
basis, it has been suggested that EmrKY might contribute to the survival of Shigella within macrophages
by safeguarding cells from DNA damaging compounds.
6. Role of the MFS EPs in Bacterial Communication and Biofilm Formation
Communication between bacteria and the external environment, as well as among bacteria within
the same ecological niche, is pivotal for adaptation to new habitats. It allows survival under stressful
conditions and, in the case of pathogenic bacteria, is usually highly relevant to the infectious process.
A sophisticated intercellular communication mechanism is represented by quorum sensing. Under high
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cell density signal molecules accumulate and bind to specific transcriptional activators triggering
a range of processes, including virulence, biofilm formation, and drug resistance. An interesting
case of MFS EP involved in quorum sensing is the MDR EmrCAB EP of Chromobacterium violaceum,
a Gram-negative opportunistic human pathogen usually found in water and soil. EmrCAB is encoded
by a large operon similar to EmRAB but also including the gene for a TolC-like outer membrane
component [37] (Figure 2). It is regulated by a MarR-like repressor, EmrR. To control the production
of the microbicidal purple pigment violacein this microorganism exploits a quorum-sensing system
consisting of a CviI/CviR circuit which produces and receives specific acylated homoserine lactone
(AHL) autoinducers [114]. Deletion of the emrR gene induces, in addition to antibiotic resistance,
a decreased production of violacein. The combined deletion of emrCAB and emrR restores violacein
production [37], confirming that EmrR controls the synthesis of the pigment through repression of
emrCAB. It has been proposed that a high level of EmrCAB alters the quorum-sensing signaling by
exporting long-chain AHL molecules synthetized by CviI and required to activate violacein biosynthesis.
An EP similar to EmrCAB, EmRCABsm, has also been characterized in Stenotrophomonas maltophilia,
a Gram-negative opportunistic pathogen associated to cystic fibrosis and highly resistant to a broad
spectrum of antibiotics [36,115,116]. In line with previous observations on homologs of EmrCABs
in other microorganisms, this EP is negatively regulated by EmrRsm and favors the extrusion of
highly hydrophobic substrates. Considering the ubiquitous nature of S. maltophilia, this EP could have
a physiological role in allowing the bacteria to survive in their ecological niche or to export signaling
molecules [36] (Table 1).
Efflux pumps are involved in biofilm formation since, in most cases, EP encoding genes are
expressed at higher levels in biofilm-forming bacteria as compared to planktonic bacteria [117].
This constitutes a serious clinical issue as EPs are key elements in the generation of multidrug resistance,
often leading to chronic infections that are difficult to treat [117,118]. The involvement of EPs in
biofilm formation is confirmed by the ability of EP inhibitors to abolish biofilm formation [119].
E. coli mutants missing the genes for several EPs, including the MFS EPs EmrD or EmrKY, exhibit
low biofilm formation [120]. Similarly, Salmonella enterica serovar Typhimurium strains carrying
mutations in emrAB or mdfA genes, both encoding MFS EPs [119] are impaired in biofilm formation.
Although EPs have been considered mainly as devices used by biofilm-embedded bacteria to increase
resistance to antimicrobial agents, these transporters also play an important role in the metabolism of
biofilm-forming bacteria. In general, the nature of exported substrates drives biofilm formation in
a positive or negative manner [26]. In fact, bacteria can use EPs to translocate substances needed to
aggregate biofilm matrices and quorum-sensing molecules that affect biofilm formation. As for MFS
EPs, some examples of positive impact exist (Table 1). This is exemplified by the Helicobacter pylori
GluP transporter, which exports sugars such as d-glucose [121]. In H. pylori strains lacking the GluP
EP the biofilm matrix contains more cavities as compared to the wild-type. As d-glucose is involved
in the synthesis of bacterial exopolysaccharides, failed export of this important matrix component
negatively affects the correct packaging of the biofilm [92]. Similarly, during E. coli biofilm growth
the upregulation of setB, encoding an MSF EP involved in the efflux of glucose, has been surmised to
support the requirement for increased export of sugars in the biogenesis of the biofilm matrix and the
extrusion of non-metabolizable sugars that could be toxic to biofilm cells [89,117]. A further example
in E. coli is represented by EmrD [91], an EP involved in the efflux of arabinose, which promotes cell
aggregation an biofilm formation Another case in E. coli is the MDR EP TetA(C) which stimulates the
production of colanic acid, a capsular polysaccharide component of the biofilm matrix favoring biofilm
maturation [90].
In S. aureus the proP gene, encoding an MFS proline/betaine transporter, is upregulated in biofilm
as compared to planktonic growth [93]. An increased level of ProP during the initial stage of biofilm
formation may facilitate the transport of proline and betaine across the membrane protecting the
cells from osmotic stress since these osmolytes are critical for bacterial cell survival under these
conditions [122]. Another S. aureus EP involved in ensuring appropriate fitness of bacteria in biofilm
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embedded cells is NorB which, as already mentioned, contributes to bacterial survival in abscesses.
Expression of the norB gene is increased in response to hypoxic conditions and low pH within
biofilms [56]. In particular, it has been proposed that NorB may ensure that biofilm cells are protected
from the toxic effects of organic acids produced by the fermentation of glucose during anaerobic
respiration in biofilm growth.
Other MFS EPs involved in biofilm formation are found in Acinetobacter baumannii,
a multidrug-resistant human pathogen responsible for severe nosocomial infections. The clinical
relevance of A. baumannii is largely due to its ability to survive under stressful conditions by forming
biofilms [88]. Three A. baumannii MFS EPs are involved in biofilm formation: Pmt, AbaF, and AbaQ.
The Pmt transporter is encoded by a gene expressed at significantly higher levels in biofilm cells as
compared to planktonic cells [88]. By monitoring the amount of extracellular DNA (eDNA) released
by strains overexpressing pmt, Sahu et al. [123] proposed the involvement of the Pmt EP in nucleic acid
transport. Since DNA and RNA are well-known scaffolding components of the biofilm matrix [124],
the authors [123] have inferred that an increase in eDNA supports a more abundant development of
the bacterial biofilm. Another MFS transporter involved in biofilm formation is AbaF, responsible for
the efflux of fosfomycin. Disruption of the abaF gene limits the capacity to form biofilms, probably
because of a reduced efflux of biofilm matrix compounds. Moreover, using the Caenorhabditis elegans
model, it has been shown that worms infected with A. baumannii abaF defective strains survive longer
than those infected with the wild-type strain, suggesting that abaF mutants have a reduced capacity to
expel host-derived antibacterial factors [86]. Finally, it has been shown that the lack of abaQ, a gene
encoding a MFS transporter, significantly reduces bacterial surface-associated motility and virulence
in a C. elegans model [87]. Interestingly, loss of motility and reduced virulence was also observed in
a biofilm-hyperproducing A. baumanni clinical strain deleted in abaQ. Considering the relevant role
of bacterial motility in the first stage of biofilm generation, it is likely that AbaQ also contributes to
A. baumanni virulence allowing an efficient biofilm formation. Altogether this evidence suggests that
inhibiting the synthesis of EP components may constitute a novel effective approach to overcome the
increasing emergence of biofilm-based infections.
7. Conclusions
In recent years, a considerable amount of knowledge on the mechanisms, regulation, and physiological
functions of MFS EPs has been acquired in several bacterial systems. This has led to a deeper
understanding of the varied biological roles of this EP family, which go beyond simple drug transport
and also affect resistance to plant and mammalian defence systems, virulence, and community
behaviors. In several cases, the major role is still not fully elucidated. However, evidence accumulated
so far strongly suggests that extrusion of antibiotics is not the original physiological function of
MDR EPs, which should rather be regarded as sophisticated machines contributing to optimize
bacterial interactions with other cells and with the environment. The complexity of the regulatory
systems underlying the expression of EPs is in line with the need to rapidly and coordinately activate
expression of EP genes in response to a broad range of substrates and environmental signals. Overall,
further investigations on the function of EPs can be anticipated to open new perspectives for a better
comprehension of the physiology of bacterial cells and of the elaborate interplay of bacteria with
their hosts.
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